Nutriband to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference

Nutriband Inc. (NASDAQ: NTRB) announced that Chairman Serguei Melnik will present at Noble Capital Markets' Emerging Growth Virtual Equity Conference on Wednesday, October 8, 2025, at 3 p.m. ET. The presentation will feature a fireside Q&A session with questions from the live virtual audience, providing investors with direct access to company leadership. Registered investors will have the additional opportunity to schedule one-on-one meetings with Melnik following the presentation.

The conference participation represents a significant opportunity for Nutriband to showcase its innovative pharmaceutical development pipeline to the investment community. The company is primarily engaged in developing a portfolio of transdermal pharmaceutical products, with its lead product being an abuse-deterrent fentanyl patch incorporating the proprietary AVERSA™ technology. This technology platform can be incorporated into any transdermal patch to prevent abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Interested attendees can register for the conference at no cost through the official conference website. The virtual format provides broad accessibility for investors worldwide to engage with the company's leadership and learn about Nutriband's progress in developing solutions to address the ongoing opioid crisis. A video webcast of the presentation will be available on Channelchek, Noble's investor portal, and will be archived for 90 days on both Channelchek.com and Nutriband's corporate website at www.nutriband.com.

The timing of this presentation comes as the pharmaceutical industry continues to face pressure to develop safer alternatives to existing opioid delivery systems. Nutriband's AVERSA™ technology represents a potentially significant advancement in transdermal drug delivery safety, particularly for high-risk medications like fentanyl. The ability to prevent abuse and misuse of transdermal patches could have substantial implications for patient safety and public health, addressing a critical need in pain management therapeutics.

For investors seeking additional information about Nutriband, the company maintains a newsroom at https://ibn.fm/NTRB where the latest updates and developments are available. The Emerging Growth Virtual Equity Conference presentation provides a platform for Nutriband to demonstrate its progress in developing innovative pharmaceutical solutions while engaging directly with the investment community about the company's strategic direction and market potential.